Lipid metabolic changes during hormonal treatment of endometriosis

article OA: closed CC0 ⤵ 5 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
AI-generated summary by claude@2026-06, 2026-06-11

This study investigated alterations in lipid metabolism in patients undergoing hormonal treatment for endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Endometriosis Lipid Metabolism Lynestrenol Medroxyprogesterone Pelvic Neoplasms Pregnadienes Adult Apolipoprotein A-I Apolipoproteins A Apolipoproteins A Apolipoproteins B Apolipoproteins B Cholesterol Cholesterol Cholesterol, HDL Cholesterol, HDL Cholesterol, LDL Cholesterol, LDL Danazol

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (28)

Cited by (5)

SciLite annotations

chemicals 16
lipid medroxyprogesterone acetate lynestrenol danazol cholesterol triglyceride lipoprotein cholesterol lipoprotein lipid lipoprotein lipoprotein lipoprotein cholesterol triglyceride
organisms 1
noordeloos 2009062

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:09:20.810540+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK